Encision Inc (ECIA) stock
ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $163.15KP/E –Yield –
Encision net income
Net income is the profit left for shareholders after every expense, interest and tax.
Encision's net income for the twelve months ending Sep 30, 2025 was -$380.94K. For fiscal 2025 it was -$220.20K. The highest annual figure on record is $584.73K in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$220.20K | – |
| FY2024 | Mar 31, 2024 | -$691.78K | – |
| FY2023 | Mar 31, 2023 | -$323.95K | – |
| FY2022 | Mar 31, 2022 | -$65.59K | -111.2% |
| FY2021 | Mar 31, 2021 | $584.73K | – |
| FY2020 | Mar 31, 2020 | -$198.31K | – |
| FY2019 | Mar 31, 2019 | -$236.10K | -170.4% |
| FY2018 | Mar 31, 2018 | $335.56K | – |
| FY2017 | Mar 31, 2017 | -$729.29K | – |
| FY2016 | Mar 31, 2016 | -$880.20K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$267.83K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$41.13K | -286.6% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$47.31K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$24.67K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$170.26K | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $22.04K | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$336.67K | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$207.13K | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$7.53K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$140.45K | -153.1% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$92.89K | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$216.33K | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$279.32K | -177.7% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $264.60K | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$402.31K | -447.0% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$16.01K | -102.7% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $359.57K | +3992.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$6.84K | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $115.93K | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $599.32K | +754.9% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $8.79K | -70.6% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$139.31K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$116.41K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $70.10K | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $29.89K | +142.7% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$181.89K | -1078.8% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$182.59K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | -$84.40K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $12.31K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $18.58K | – |
See a number that looks wrong?